1. Introduction {#sec1-nutrients-11-00896}
===============

Age-related hearing loss (ARHL) or presbycusis is a progressive, bilateral, symmetrical sensorineural hearing loss. ARHL is a result of degeneration of the cochlea or associated structures of the inner ear. Approximately ARHL affects 23% to 40% of the population older than 65 years of age \[[@B1-nutrients-11-00896]\].

Disabling hearing loss was defined as better ear hearing more than 40 dB (average of 0.5, 1, 2, and 4 kHz) in adults according to the World Health Organization (WHO) \[[@B2-nutrients-11-00896]\]. In 2012, the WHO estimated that there were 328 million adults with disabling hearing loss worldwide. Because of the aging population, the WHO suggested that more than 500 million will suffer from significant ARHL by 2025 \[[@B2-nutrients-11-00896]\]. ARHL is associated with increased cognitive dysfunction and dementia in the elderly \[[@B3-nutrients-11-00896],[@B4-nutrients-11-00896],[@B5-nutrients-11-00896]\], which can lead to social isolation, depression, and anxiety \[[@B6-nutrients-11-00896]\]. ARHL is irreversible; therefore, understanding potential modifying factors associated with ARHL is critical for prevention.

Nutritional status or nutritional factors for the elderly are known to cause many problems related to aging, and emerging studies have suggested that there are interaction effects between nutrition and ARHL \[[@B7-nutrients-11-00896],[@B8-nutrients-11-00896]\]. Metabolic syndrome is affected by nutritional status or nutritional factors \[[@B9-nutrients-11-00896]\], and we recently identified an association between metabolic syndrome and ARHL in a 5-year follow-up and large cohort study \[[@B10-nutrients-11-00896]\].

To reduce the risk of ARHL, it is important to identify protective nutritional factors. The Korean National Health and Nutrition Examination Survey (KNHANES) may be useful for determining whether or not there are protective nutritional factors. This survey collects comprehensive information, such as health status and nutritional condition from the general Korean population, using a complex, stratified, multistage, probability-clustered sampling method based on national census data.

Two studies have investigated the relationship between nutrition and hearing loss using KNHANES data. One study reported a relationship between vitamins and ARHL, but there was a limitation of research to the population included for one year only in 2011, rather than the total of 3 years from 2010 to 2012 in the fifth KNHANES \[[@B11-nutrients-11-00896]\]. The other study analyzed energy-related nutritional factors such as proteins, fats and carbohydrates, and found that low fat and low protein intake were associated with ARHL using the fifth KNHANES data, but defined hearing loss as ≥ 25 dB, which does not cause a major disability, rather than the ≥40 dB criterion for disabling hearing loss established by the WHO \[[@B12-nutrients-11-00896]\].

In this study, we aimed to investigate the possible impact of dietary nutrients on ARHL using data from the fifth KNHANES, which includes cross-sectional surveys of subjects from 2010 through 2012. The population of overall disabling hearing loss included 10% of total participants, and up to 40% in the population older than 65 years \[[@B13-nutrients-11-00896]\]. Because we wanted to analyze the relationship between ARHL and nutrition in the age group in which ARHL was mainly observed, we focused on this study only over 65 years of age.

2. Materials and Methods {#sec2-nutrients-11-00896}
========================

2.1. Study Participant {#sec2dot1-nutrients-11-00896}
----------------------

This study used data from the fifth KNHANES. The KNHANES is an ongoing nationwide epidemiological study conducted by the Korea Centers for Disease Control and Prevention of the Ministry of Health and Welfare. The institutional review board (IRB) of the Korean Centers for Disease Control and Prevention review and approve the KNHANES survey annually. All participants are randomly chosen from randomly assigned districts of cities and provinces in South Korea. Among the selected candidate population, 80.8% of individuals participated in the fifth KNHANES from 2010 to 2012. Written informed consent was obtained from all participants before commencement of the study.

During the period of the Fifth KNHANES, the total number of participants was 36,067 individuals. Among those 36,067 participants, 4742 subjects aged ≥ 65 years were included. Among the 4742 participants aged ≥ 65, 1022 participants were excluded because they had not received an audiometric test or had an abnormal tympanic membrane or had not completed the nutritional survey or had incomplete data ([Figure 1](#nutrients-11-00896-f001){ref-type="fig"}).

2.2. Otologic Examination and Audiologic Evaluation {#sec2dot2-nutrients-11-00896}
---------------------------------------------------

During the fifth KNHANES survey, otologic examinations were conducted by ENT doctors by using a 4-mm, 0° endoscope (Xion GmbH, Berlin, Germany) to evaluate any abnormalities related to the tympanic membrane or middle ear including retraction, otitis media with effusion and cholesteatoma. Audiologic evaluation was performed by using a diagnostic audiometer (SA-203; Entomed, Malmoe, Sweden) at 0.5, 1, 2, 3, 4 and 6 kHz in a soundproof booth. Hearing impairment was defined as a hearing level exceeding an average of 40 dB on pure-tone audiometry at 0.5, 1, 2 and 4 kHz. Hearing impairment was divided into bilateral hearing loss, considered ARHL, and unilateral hearing loss.

2.3. Evaluation of Nutrition Intake {#sec2dot3-nutrients-11-00896}
-----------------------------------

Nutrition intake was surveyed using the complete 24-h recall method. All participants were instructed to continue their ordinary diets before the 24-h recall evaluation. Answers were not excluded by any certain days such as holidays or weekends. Nutrient intake was calculated by referencing the nutrient concentrations of foods described in the Korean Food Composition Table, which was devised by the Korean National Rural Resources Development Institute \[[@B14-nutrients-11-00896]\]. As shown in a previous report \[[@B15-nutrients-11-00896]\], the analyzed nutrient intake data included total energy (kJ/day (kcal/day)), protein (g/day), fat (g/day), carbohydrate (g/day), crude fiber (g/day), ash (g/day), calcium (mg/day), phosphorus (mg/day), iron (mg/day), sodium (mg/day), potassium (mg/day), β-carotene (µg/day), retinol (µg/day), thiamine (mg/day), riboflavin (mg/day), niacin (mg/day), and Vitamin C (mg/day). The intake of vitamin A (µg retinol equivalents (RE)/day) was calculated by addition of retinol (µg/day) and β-carotene/6 (µg/day). The subjects were divided into quartile groups of intake per day for each nutrient.

2.4. Statistical Analyses {#sec2dot4-nutrients-11-00896}
-------------------------

The general characteristics between subjects with and without bilateral hearing impairment were compared using Student's *t*-tests for continuous parameters and χ^2^ tests for categorical parameters. Nutrient intakes were analyzed by quartiles, and the lowest quartile was the reference group. Univariate analyses of each nutrient were performed to investigate factors associated with hearing impairment. Multivariate logistic regression analyses were used to confirm the association between hearing impairment and each nutritional factor. The analyses were adjusted for the following potential confounders: age, sex, body mass index (BMI), smoking status, alcohol consumption, hypertension, and diabetes mellitus. The results of the logistic regression analyses are expressed as odds ratios (OR) with 95% confidence intervals (CI). *p* values of \<0.05 were considered statistically significant. All statistical analyses were performed using SPSS software (version 21.0; IBM Corp., Armonk, NY, USA).

3. Results {#sec3-nutrients-11-00896}
==========

Participant demographics are shown in [Table 1](#nutrients-11-00896-t001){ref-type="table"}. The occurrence of bilateral hearing loss exceeding an average of 40 dB was 17.88% (*n* = 665) in the over 65 years of age group. The average age of subjects with bilateral hearing loss was 75.4 ± 5.99 years old. Subjects with bilateral hearing impairment were older (*p* \< 0.001), weighed less (*p* \< 0.001), and were more likely to smoke (*p* = 0.0023) and to drink alcohol (*p* \< 0.001) than those without bilateral hearing impairment.

Quartile values of each nutrient intake are shown in [Table 2](#nutrients-11-00896-t002){ref-type="table"}.

[Table 3](#nutrients-11-00896-t003){ref-type="table"} shows the associations between nutrient intake and bilateral hearing impairment. The highest quartiles (75th--100th percentile) of all nutrients except for β-carotene showed significantly lower risk for bilateral hearing impairment (all *p* \< 0.05) in the univariate analyses. In univariate analyses, the third quartiles (50th--75th percentile) of intake of fat (*p* = 0.007), protein (*p* = 0.005), ASH (*p* = 0.001), calcium (*p* = 0.007), iron (*p* = 0.011), retinol (*p* = 0.006), thiamin (*p* = 0.001), riboflavin (*p* = 0.006), niacin (*p* = 0.032), potassium (*p* = 0.005), and phosphorus (*p* = 0.001) showed significantly lower risk for bilateral hearing impairment. The second quartiles (25th--50th percentile) of carbohydrate (*p* = 0.024), fat (*p* = 0.037), calcium (*p* = 0.012), and iron (*p* = 0.040) showed significantly lower risk for bilateral hearing impairment in the univariate analyses. Multivariate analyses adjusted for age, sex, BMI, smoking status, alcohol consumption, hypertension, and diabetes mellitus showed significantly lower risk for bilateral hearing impairment in the highest quartiles of intake for riboflavin (aOR, 0.71; 95% CI, 0.54--0.94; *p* = 0.016), niacin (aOR, 0.72; 95% CI, 0.54--0.96; *p* = 0.025), and retinol (aOR 0.66; 95% CI, 0.51--0.86; *p* = 0.002).

[Table 4](#nutrients-11-00896-t004){ref-type="table"} shows the results of the association between nutrient intake and unilateral hearing impairment. In univariate analyses, the third quartiles of intake of riboflavin (*p* = 0.042), retinol (*p* = 0.015), iron (*p* = 0.003), calcium (*p* = 0.022) and sodium (*p* = 0.003) showed significantly lower risk for unilateral hearing impairment. In addition, the highest quartiles of intake of β-carotene (*p* = 0.031), and vitamin A (*p* = 0.048) showed an inverse correlation with the prevalence of unilateral hearing loss. However, in multivariate analyses adjusted for age, sex, BMI, smoking status, alcohol consumption, hypertension, and diabetes mellitus showed no correlation between nutrient intake and unilateral hearing impairment.

4. Discussion {#sec4-nutrients-11-00896}
=============

We found that dietary intake of riboflavin, niacin and retinol were associated with bilateral hearing impairment in elderly KNHANES participants, but there was no correlation between nutrient intake and unilateral hearing impairment. Overall, higher intake of riboflavin, niacin and retinol were related to a lower risk of ARHL.

According to the Dietary Reference Intakes for Koreans 2015, the average requirement of riboflavin is 1.0 mg/day and the recommended intake is 1.2 mg/day for ages 65 years and older \[[@B16-nutrients-11-00896]\]. In this study, only the highest quartile of riboflavin intake satisfied the average requirement and the recommended intake. The average requirement of niacin was 11 mg/day, and the recommended intake is 14 mg/day for age 65 years or older. The average requirement of niacin was met in the third and fourth quartiles of niacin intake, but only the highest quartile met the recommended intake. Retinol is defined in the dietary reference intakes for Koreans.

Increased serum level or dietary intake of retinol decreased the incidence of ARHL in various countries such as Asian and Western countries \[[@B17-nutrients-11-00896],[@B18-nutrients-11-00896],[@B19-nutrients-11-00896]\]. Higher riboflavin intakes in western countries are significantly associated with better hearing thresholds \[[@B18-nutrients-11-00896]\], but there have been no reports in Asian countries. In a Korean study, dietary intake of niacin was inversely correlated with ARHL, but there was no significant difference after adjusting for age, sex, smoking history, BMI, and medical history (diabetes, hypertension) \[[@B11-nutrients-11-00896]\]. Vitamin C was reported to be associated with better hearing in a Korean study \[[@B11-nutrients-11-00896]\], but there was no relationship between intake of vitamin C and ARHL in some studies \[[@B18-nutrients-11-00896],[@B20-nutrients-11-00896]\]. In addition, our results also showed that vitamin C was not associated with ARHL.

There have been several studies evaluating the relationship between retinol and hearing, as retinol has a high concentration in the inner ear \[[@B21-nutrients-11-00896]\], and retinoic acid, an active metabolite of retinol, contributes to development of the organ of Corti \[[@B22-nutrients-11-00896]\]. The relationship between retinol and hearing loss was reported in many of these studies \[[@B8-nutrients-11-00896],[@B17-nutrients-11-00896],[@B18-nutrients-11-00896],[@B19-nutrients-11-00896],[@B21-nutrients-11-00896],[@B22-nutrients-11-00896],[@B23-nutrients-11-00896],[@B24-nutrients-11-00896]\]. Higher intake of retinol was associated with better hearing in women \[[@B19-nutrients-11-00896]\]. In regarding to the dietary intake of retinol, the risk of ARHL (\>40 dB HL) was lower in the highest quintile compared to the lowest quintile in older adults \[[@B18-nutrients-11-00896]\]. Increased serum retinol has also been associated with reduced incidence of ARHL \[[@B17-nutrients-11-00896]\]. The role of retinol in the prevention of hearing loss has not yet been determined. Reported potential mechanisms for the prevention of hearing loss suggest that retinoic acid inhibits an apoptosis-related c-Jun N-terminal kinase signal pathway in the inner ear \[[@B23-nutrients-11-00896]\], or that it facilitate regeneration of auditory hair cells \[[@B24-nutrients-11-00896]\]. Another possible way that retinol may prevent hearing loss lies in its antioxidant properties \[[@B25-nutrients-11-00896]\], although there is some controversy about whether retinol is an antioxidant \[[@B26-nutrients-11-00896]\].

Riboflavin also has an antioxidant role, especially with respect to lipid peroxidation and reperfusion oxidative injury \[[@B27-nutrients-11-00896]\]. Riboflavin, by itself or as a part of glutathione reductase, is a fundamental component of the antioxidant mechanisms within cell systems. Riboflavin affects the process of glutathione conversion and shows an antioxidant activity. By glutathione reductase (GR) with riboflavin (in the flavin adenine dinucleotide coenzyme form), oxidized glutathione is converted to its reduced form (GSH) \[[@B28-nutrients-11-00896]\]. GSH serves as an endogenous antioxidant in every cell in the body \[[@B29-nutrients-11-00896]\]. Riboflavin can decrease oxidative damages as free radical scavengers \[[@B25-nutrients-11-00896]\]. It also reduces reactive oxygen species (ROS) and peroxides such as hydroperoxides. Therefore, riboflavin deficiency may lead to increased risk of ARHL due to oxidative stress and ROS production.

ARHL is caused by irreversible loss of sensory hair cells and/or degeneration of spiral ganglion neurons. Niacin increases synaptic plasticity and axonal growth in a rat model of stroke \[[@B30-nutrients-11-00896]\]. Such findings suggest that niacin-induced neuroprotective effects increase brain-derived neurotrophic factor (BDNF)/tropomyosinreceptor kinase B (TrKB) pathways after a stroke \[[@B30-nutrients-11-00896]\]. The survival of spiral ganglion neurons (SGNs) of the cochlear is retained by endogenous neurotrophic support \[[@B31-nutrients-11-00896]\]. Therefore, the risk of ARHL may be reduced by upregulated BDNF by niacin intake. When the dietary niacin intake was higher, vascular endothelial cell function increased \[[@B32-nutrients-11-00896]\]. Endothelial dysfunction could lead to interruption of vascular flow of the inner ear. In idiopathic sudden sensorineural hearing loss (ISSHL), compromised vascular endothelial cell function has been reported \[[@B33-nutrients-11-00896]\]. Therefore, improved vascular endothelial cell function induced by niacin could reduce the risk for ARHL.

This report may be the first community-based epidemiological study to reveal that higher intake of niacin is inversely associated with the prevalence of ARHL in the elderly. However, we could not find the causal mechanism of the higher intake of niacin and ARHL. Therefore, measurement of serum of niacin in ARHL patients or animal study with niacin deficiency model will be needed to understand the relationship between niacin and hearing.

In multivariate analysis, higher dietary intake of riboflavin, niacin and retinol had a strong correlation with ARHL. These results were fairly consistent with previous studies in which a healthy diet including multivitamins influenced better hearing \[[@B34-nutrients-11-00896],[@B35-nutrients-11-00896]\]. Vitamin intake decreased with age \[[@B11-nutrients-11-00896]\]; therefore, supplementary vitamin intake may be more effective for hearing in the elderly.

Retinol and riboflavin are mainly found in foods of animal origin like milk, cheese, and eggs. Niacin is found in a variety of whole and processed foods, including meat from various animal sources, seafood, and spices. The principal aspects of traditional Korean diet include proportionally high consumption of rice and vegetables, moderate consumption of fish, and low consumption of red meat and dairy products \[[@B36-nutrients-11-00896]\]. Over the last few decades, the Korean diet has changed from traditional food, mainly composed of rice and vegetables, to a westernized diet, rich in red meat and dairy products, in line with development and globalization \[[@B37-nutrients-11-00896]\]. However, the elderly in Korea may not have enough riboflavin, niacin, and retinol, because they maintain traditional Korean diets, including low consumption of meat and milk.

As a cross-sectional epidemiological survey, our study cannot establish causal relationships between the nutritional intake and ARHL. To identify causal relationships, an experimental study using human or animal would be needed. Furthermore, nutritional intake was estimated based on the 24-h recall method of the subjects. Although trained staff interviewed the participants, responses were dependent on the subjects' memory, leaving open the possibility of measurement error. Serum analysis of nutrient levels could be useful when investigating their direct association with ARHL, because nutritional bioavailability may vary from person to person.

5. Conclusions {#sec5-nutrients-11-00896}
==============

In conclusion, our study found that higher intake of riboflavin, niacin and retinol were inversely correlated with prevalence of bilateral hearing loss in the ≥65 years age group. ARHL was lower in the groups taking niacin and riboflavin above the recommended intake. Although Koreans have continued to adopt more western diets, traditional grain- and vegetable-oriented eating habits are still maintained by the elderly. Therefore, encouraging the consumption of dairy products and meat to ensure sufficient supplies of riboflavin, niacin, and retinol in older populations may help reduce the incidence of ARHL.
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nutrients-11-00896-t001_Table 1

###### 

Baseline characteristics of study participants.

  Characteristics        Bilateral Age-Related Hearing Loss (≥40 dB)   *p* Value      
  ---------------------- --------------------------------------------- -------------- ---------
  **Age**                71.78 ± 4.83                                  75.40 ± 5.99   \<0.001
  Gender                                                                              \<0.001
  Male                   1298 (42.5)                                   337 (50.7)     
  Female                 1757 (57.5)                                   328 (49.3)     
  BMI (kg/m²)                                                                         \<0.001
  Underweight (\<18.5)   106 (3.5)                                     41 (6.2)       
  Normal (≥18.5, \<23)   1873 (61.3)                                   458 (68.9)     
  Over (≥23)             1076 (35.2)                                   166 (24.9)     
  Smoking                                                                             0.0023
  Never                  1869 (61.2)                                   364 (54.7)     
  Former                 843 (27.6)                                    200 (30.1)     
  Current                343 (11.2)                                    101 (15.2)     
  Alcohol consumption                                                                 \<0.001
  Non                    1523 (49.9)                                   387 (58.2)     
  in month\<1            482 (15.8)                                    70 (10.5)      
  1≤in month≤4           535 (17.5)                                    103 (15.5)     
  2≤in week              515 (16.8)                                    105 (15.8)     
  Diabetes                                                                            0.87
  No                     2475 (81.0)                                   537 (80.8)     
  Yes                    580 (19.0)                                    128 (19.2)     
  Hypertension                                                                        0.197
  No                     1441 (47.2)                                   332 (49.9)     
  Yes                    1614 (52.8)                                   333 (50.1)     

Data are presented as mean ± SD, number (%). BMI, body mass index.

nutrients-11-00896-t002_Table 2

###### 

Quartile categories of nutrient intake.

  Nutrient                                  Quartile 1   Quartile 2         Quartile 3         Quartile 4
  ----------------------------------------- ------------ ------------------ ------------------ ------------
  Total energy intake (kcal)                \<1239.64    1239.64--1599.27   1599.28--2028.59   2028.60≤
  Carbohydrate (g/day)                      \<229.03     229.03--296.03     296.04--367.13     367.14≤
  Fat (g/day)                               \<10.16      10.16--17.89       17.90--31.13       31.14≤
  Protein (g/day)                           \<35.03      35.03--48.96       48.97--68.07       68.08≤
  Fiber (g/day)                             \<3.81       3.81--5.76         5.77--8.69         8.70≤
  Ash (g/day)                               \<9.74       9.74--14.54        14.55--21.07       21.08≤
  Calcium (mg/day)                          \<217.14     217.14--350.01     350.02--543.39     543.40≤
  Iron (mg/day)                             \<6.85       6.85--10.58        10.59--16.71       16.72≤
  Potassium (mg/day)                        \<1601.38    1601.38--2289.28   2289.29--3224.92   3224.93≤
  Sodium (mg/day)                           \<2104.36    2104.36--3376.17   3376.18--5195.31   5195.32≤
  Phosphorus (mg/day)                       \<683.91     683.91--920.32     920.33--1217.36    1217.37≤
  Retinol (μg/day)                          \<3.22       3.22--15.51        15.52--60.55       60.56≤
  β-carotene (μg/day)                       \<1020.92    1020.92--2237.26   2237.27--4412.40   4412.41≤
  Vitamin A (μg Retinol Equivalents /day)   \<208.76     208.76--426.34     426.35--816.56     816.57≤
  Thiamin (mg/day)                          \<0.64       0.64--0.90         0.91--1.29         1.30≤
  Riboflavin (mg/day)                       \<0.50       0.50--0.74         0.75--1.13         1.14≤
  Niacin (mg/day)                           \<8.26       8.26--11.59        11.60--16.35       16.36≤
  Vitamin C (mg/day)                        \<36.17      36.17--66.36       66.37--114.93      114.94≤

nutrients-11-00896-t003_Table 3

###### 

Odds ratios of nutritional factors and bilateral hearing loss.

  Nutrient           Univariable Analysis   Multivariable Analysis   Nutrient           Univariable Analysis   Multivariable Analysis                                                    
  ------------------ ---------------------- ------------------------ ------------------ ---------------------- ------------------------ ------------------ ---------- ------------------ ----------
  **Total Energy**                                                                                             Retinol                                                                   
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.77(0.61--0.98)       0.030 \*                 0.82(0.63--1.06)   0.132                  Q2                       0.97(0.78--1.22)   0.819      1.05(0.82--1.34)   0.700
  Q3                 0.80(0.63--1.00)       0.054                    0.87(0.67--1.13)   0.285                  Q3                       0.72(0.59--0.91)   0.006 \*   0.79(0.61--1.02)   0.075
  Q4                 0.66(0.52--0.84)       0.001 \*                 0.80(0.61--1.06)   0.125                  Q4                       0.61(0.48--0.78)   0.001 \*   0.66(0.51--0.86)   0.002 \*
  Carbohydrate                                                                                                 β-carotene                                                                
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.76(0.60--0.97)       0.024 \*                 0.88(0.68--1.14)   0.321                  Q2                       1.10(0.88--1.39)   0.412      1.23(0.96--1.58)   0.105
  Q3                 0.86(0.68--1.08)       0.198                    0.92(0.71--1.19)   0.527                  Q3                       0.90(0.71--1.14)   0.364      1.08(0.83--1.39)   0.576
  Q4                 0.73(0.58--0.93)       0.010 \*                 0.93(0.71--1.22)   0.588                  Q4                       0.80(0.63--1.01)   0.065      1.00(0.77--1.31)   0.981
  Fat                                                                                                          Vitamin A                                                                 
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.78(0.62--0.99)       0.037 \*                 0.92(0.72--1.18)   0.522                  Q2                       0.95(0.76--1.20)   0.683      1.03(0.80--1.32)   0.828
  Q3                 0.73(0.58--0.92)       0.007 \*                 0.81(0.62--1.04)   0.102                  Q3                       0.83(0.65--1.04)   0.108      0.99(0.77--1.28)   0.915
  Q4                 0.62(0.49--0.79)       0.001 \*                 0.76(0.58--1.01)   0.052                  Q4                       0.72(0.56--0.91)   0.006 \*   0.86(0.66--1.12)   0.270
  Protein                                                                                                      Thiamin                                                                   
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.86(0.68--1.08)       0.185                    0.99(0.77--1.27)   0.919                  Q2                       0.87(0.70--1.09)   0.228      0.98(0.76--1.25)   0.845
  Q3                 0.71(0.56--0.90)       0.005 \*                 0.87(0.67--1.14)   0.312                  Q3                       0.66(0.53--0.84)   0.001 \*   0.78(0.60--1.02)   0.070
  Q4                 0.63(0.49--0.80)       0.001 \*                 0.75(0.57--1.01)   0.053                  Q4                       0.64(0.51--0.82)   0.001 \*   0.82(0.62--1.08)   0.152
  Fiber                                                                                                        Riboflavin                                                                
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.85(0.68--1.07)       0.175                    .97(0.75--1.25)    0.798                  Q2                       0.82(0.65--1.03)   0.085      0.91(0.71--1.17)   0.459
  Q3                 0.91(0.72--1.14)       0.413                    1.11(0.86--1.43)   0.418                  Q3                       0.72(0.58--0.91)   0.006 \*   0.86(0.67--1.11)   0.258
  Q4                 0.67(0.52--0.85)       0.001 \*                 .89(0.68--1.17)    0.404                  Q4                       0.56(0.44--0.71)   0.001 \*   0.71(0.54--0.94)   0.016 \*
  ASH                                                                                                          Niacin                                                                    
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.80(0.64--1.00)       0.051                    0.87(0.68--1.12)   0.278                  Q2                       1.03(0.83--1.30)   0.775      1.19(0.93--1.42)   0.174
  Q3                 0.64(0.61--0.81)       0.001 \*                 0.76(0.58--0.01)   0.054                  Q3                       0.77(0.61--0.98)   0.032 \*   0.95(0.73--1.23)   0.675
  Q4                 0.62(0.49--0.79)       0.001 \*                 0.77(0.59--1.01)   0.062                  Q4                       0.59(0.46--0.76)   0.001 \*   0.72(0.54--0.96)   0.025 \*
  Calcium                                                                                                      Vitamin C                                                                 
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.74(0.59--0.94)       0.012 \*                 0.91(0.70--1.17)   0.439                  Q2                       0.83(0.66--1.05)   0.115      0.97(0.75--1.24)   0.790
  Q3                 0.73(0.58--0.92)       0.007 \*                 0.95(0.73--1.23)   0.679                  Q3                       0.81(0.65--1.02)   0.079      0.99(0.77--1.28)   0.945
  Q4                 0.68(0.54--0.86)       0.001 \*                 0.88(0.67--1.14)   0.327                  Q4                       0.63(0.50--0.80)   0.001 \*   0.83(0.64--1.09)   0.180
  Iron                                                                                                         Potassium                                                                 
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.79(0.62--0.99)       0.040 \*                 0.88(0.68--1.13)   0.314                  Q2                       0.88(0.70--1.10)   0.252      0.99(0.78--1.28)   0.978
  Q3                 0.74(0.59--0.93)       0.011 \*                 0.89(0.68--1.15)   0.357                  Q3                       0.72(0.57--0.90)   0.005 \*   0.91(0.70--1.17)   0.454
  Q4                 0.71(0.56--0.89)       0.004 \*                 0.88(0.68--1.14)   0.330                  Q4                       0.57(0.45--0.72)   0.001 \*   0.79(0.60--1.04)   0.091
  Sodium                                                                                                       Phosphorus                                                                
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.88(0.70--1.10)       0.263                    0.96(0.75--1.24)   0.754                  Q2                       0.97(0.78--1.21)   0.776      1.12(0.88--1.43)   0.365
  Q3                 0.86(0.69--1.09)       0.216                    0.96(0.74--1.24)   0.730                  Q3                       0.67(0.53--0.85)   0.001 \*   0.77(0.59--1.01)   0.055
  Q4                 0.71(0.56--091)        0.004 \*                 0.85(0.65--1.12)   0.251                  Q4                       0.59(0.46--0.75)   0.001 \*   0.76(0.57--1.01)   0.055

Data are presented OR (95% CI). Statistics were carried out using Logistic regression. Multivariable analysis was adjusted for age, sex, body mass index (BMI), smoking status, alcohol consumption, hypertension, and diabetes mellitus. CI, confidence interval; OR, odds ratio. \* *p* \< 0.05.
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###### 

Odds ratios of nutritional factors for unilateral hearing loss.

  Nutrient           Univariable Analysis   Multivariable Analysis   Nutrient           Univariable Analysis   Multivariable Analysis                                                    
  ------------------ ---------------------- ------------------------ ------------------ ---------------------- ------------------------ ------------------ ---------- ------------------ -------
  **Total Energy**                                                                                             Retinol                                                                   
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 1.07(0.84--1.35)       0.587                    1.03(0.81--1.32)   0.783                  Q2                       0.96(0.77--1.21)   0.726      0.96(0.76--1.21)   0.741
  Q3                 1.03(0.81--1.31)       0.808                    1.02(0.79--1.31)   0.893                  Q3                       0.74(0.59--0.95)   0.015 \*   0.83(0.57--1.03)   0.054
  Q4                 1.06(0.84--1.34)       0.629                    1.02(0.78--1.33)   0.895                  Q4                       0.86(0.68--1.09)   0.213      0.88(0.69--1.11)   0.281
  Carbohydrate                                                                                                 β-carotene                                                                
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 1.21(0.95--1.54)       0.116                    1.20(0.94--1.54)   0.145                  Q2                       0.87(0.69--1.10)   0.240      0.86(0.68--1.09)   0.212
  Q3                 1.13(0.89--1.43)       0.327                    1.12(0.87--1.44)   0.364                  Q3                       0.83(0.66--1.04)   0.110      0.85(0.67--1.07)   0.166
  Q4                 1.15(0.91--1.46)       0.246                    1.15(0.89--1.49)   0.284                  Q4                       0.77(0.61--0.98)   0.031 \*   0.79(0.62--1.01)   0.059
  Fat                                                                                                          Vitamin A                                                                 
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.96(0.76--1.21)       0.721                    0.92(0.73--1.17)   0.510                  Q2                       0.91(0.73--1.15)   0.446      0.90(0.71--1.14)   0.378
  Q3                 0.88(0.69--1.11)       0.278                    0.85(0.67--1.09)   0.206                  Q3                       0.81(0.64--1.03)   0.084      0.83(0.65--1.06)   0.134
  Q4                 0.92(0.73--1.17)       0.511                    0.90(0.70--1.16)   0.432                  Q4                       0.79(0.62--0.99)   0.048 \*   0.80(0.63--1.03)   0.080
  Protein                                                                                                      Thiamin                                                                   
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.85(0.67--1.08)       0.185                    0.82(0.64--1.05)   0.119                  Q2                       1.19(0.94--1.50)   0.152      1.20(0.94--1.53)   0.143
  Q3                 0.95(0.76--1.20)       0.678                    0.93(0.73--1.18)   0.535                  Q3                       1.05(0.83--1.34)   0.670      1.05(0.82--1.35)   0.693
  Q4                 0.91(0.72--1.14)       0.403                    0.88(0.68--1.13)   0.310                  Q4                       1.02(0.80--1.29)   0.902      1.01(0.78--1.31)   0.936
  Fiber                                                                                                        Riboflavin                                                                
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 1.02(0.81--1.29)       0.860                    0.97(0.76--1.23)   0.783                  Q2                       0.88(0.70--1.11)   0.289      0.88(0.70--1.12)   0.309
  Q3                 0.85(0.67--1.07)       0.164                    0.84(0.66--1.08)   0.179                  Q3                       0.78(0.62--0.99)   0.042 \*   0.78(0.61--1.01)   0.057
  Q4                 0.87(0.69--1.10)       0.253                    1.04(0.81--1.33)   0.783                  Q4                       0.85(0.67--1.07)   0.173      0.85(0.66--1.09)   0.189
  ASH                                                                                                          Niacin                                                                    
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.96(0.76--1.21)       0.720                    0.97(0.76--1.23)   0.783                  Q2                       0.96(0.76--1.21)   0.718      0.92(0.72--1.18)   0.505
  Q3                 0.84(0.66--1.07)       0.162                    0.84(0.66--1.08)   0.179                  Q3                       1.01(0.80--1.28)   0.905      1.03(0.80--1.31)   0.839
  Q4                 1.01(0.80--1.28)       0.906                    1.04(0.81--1.33)   0.783                  Q4                       0.95(0.75--1.20)   0.673      0.92(0.71--1.19)   0.510
  Calcium                                                                                                      Vitamin C                                                                 
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.93(0.74--1.17)       0.518                    0.91(0.72--1.16)   0.438                  Q2                       0.83(0.66--1.04)   0.110      0.82(0.65--1.05)   0.109
  Q3                 0.76(0.60--0.96)       0.022 \*                 0.75(0.58--1.03)   0.054                  Q3                       0.85(0.67--1.07)   0.157      0.84(0.66--1.07)   0.148
  Q4                 0.88(0.70--1.11)       0.287                    0.89(0.69--1.13)   0.334                  Q4                       0.80(0.63--1.01)   0.057      0.81(0.63--1.03)   0.087
  Iron                                                                                                         Potassium                                                                 
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.78(0.62--0.98)       0.034 \*                 0.86(0.60--1.04)   0.065                  Q2                       0.87(0.69--1.10)   0.257      0.92(0.72--1.16)   0.470
  Q3                 0.70(0.56--0.89)       0.003 \*                 0.80(0.55--1.03)   0.056                  Q3                       0.89(0.70--1.12)   0.312      0.88(0.69--1.13)   0.304
  Q4                 0.84(0.67--1.05)       0.130                    0.83(0.65--1.06)   0.135                  Q4                       0.87(0.69--1.10)   0.257      0.89(0.69--1.15)   0.364
  Sodium                                                                                                       Phosphorus                                                                
  Q1                 Reference                                       Reference                                 Q1                       Reference                     Reference          
  Q2                 0.78(0.62--0.98)       0.034 \*                 1.02(0.80--1.30)   0.903                  Q2                       0.91(0.72--1.15)   0.435      0.90(0.71--1.15)   0.398
  Q3                 0.70(0.56--0.89)       0.003 \*                 0.99(0.77--1.27)   0.931                  Q3                       0.98(0.78--1.24)   0.859      0.97(0.77--1.24)   0.787
  Q4                 0.84(0.67--1.05)       0.130                    1.07(0.83--1.38)   0.587                  Q4                       0.90(0.71--1.14)   0.367      0.88(0.68--1.14)   0.320

Data are presented OR (95% CI). Statistics were carried out using Logistic regression. Multivariable analysis was adjusted for age, sex, body mass index (BMI), smoking status, alcohol consumption, hypertension, and diabetes mellitus. CI, confidence interval; OR, odds ratio. \* *p* \< 0.05.
